Yang Jiao1, Jihang Wang1,2, Xia Yang1, Mingzhi Shen2, Hao Xue1, Jun Guo1, Wei Dong1, Yundai Chen1, Qing Xi3, Zhenhong Fu4. 1. Senior Department of Cardiology, the Sixth Medical Center of PLA General Hospital & Chinese PLA Medical School, Beijing 100853, China. 2. Department of Cardiology, Hainan Hospital, Chinese PLA General Hospital, Sanya 572000, China. 3. The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China. xiqing301@163.com. 4. Senior Department of Cardiology, the Sixth Medical Center of PLA General Hospital & Chinese PLA Medical School, Beijing 100853, China. fuzhenh@126.com.
Abstract
OBJECTIVES: This study evaluated the prognostic power of serum uric acid (UA) in predicting adverse events in elderly acute coronary syndrome (ACS) patients with diabetes mellitus (DM). METHODS: The analysis involved 718 ACS patients >80 years old whose general clinical data and baseline blood biochemical indicators were collected prospectively from January 2006 to December 2012. These patients were classified into two groups based on DM status, and then followed up after discharge. The Kaplan-Meier method was used for major adverse cardiac event (MACE) rates and all-cause mortality. Multivariate Cox regression was performed to analyze the relationship between UA level and long-term clinical prognosis. Receiver operating characteristic (ROC) curves were analyzed to predict the cutoff value of UA in elderly ACS patients with DM. There were 242 and 476 patients in the DM and non-DM (NDM) groups, respectively, and the follow-up time after discharge was 40‒120 months (median, 63 months; interquartile range, 51‒74 months). RESULTS: The all-cause mortality, cardiac mortality, and MACE rates in both DM and NDM patients were higher than those in the control group (P=0.001). All-cause mortalities, cardiac mortalities, and MACE rates in DM patients with moderate and high UA levels were significantly higher than those in the NDM group (P=0.001). Long-term survival rates decreased significantly with increased UA levels in the ACS groups (P=0.001). UA (odds ratio (OR)=2.106, 95% confidence interval (CI)=1.244‒3.568, P=0.006) was found to be an independent risk factor for all-cause mortality and MACE in elderly ACS patients with DM. The cutoff value of UA was 353.6 μmol/L (sensitivity, 67.4%; specificity, 65.7%). CONCLUSIONS: Serum UA level is a strong independent predictor of long-term all-cause death and MACE in elderly ACS patients with DM.
OBJECTIVES: This study evaluated the prognostic power of serum uric acid (UA) in predicting adverse events in elderly acute coronary syndrome (ACS) patients with diabetes mellitus (DM). METHODS: The analysis involved 718 ACS patients >80 years old whose general clinical data and baseline blood biochemical indicators were collected prospectively from January 2006 to December 2012. These patients were classified into two groups based on DM status, and then followed up after discharge. The Kaplan-Meier method was used for major adverse cardiac event (MACE) rates and all-cause mortality. Multivariate Cox regression was performed to analyze the relationship between UA level and long-term clinical prognosis. Receiver operating characteristic (ROC) curves were analyzed to predict the cutoff value of UA in elderly ACS patients with DM. There were 242 and 476 patients in the DM and non-DM (NDM) groups, respectively, and the follow-up time after discharge was 40‒120 months (median, 63 months; interquartile range, 51‒74 months). RESULTS: The all-cause mortality, cardiac mortality, and MACE rates in both DM and NDM patients were higher than those in the control group (P=0.001). All-cause mortalities, cardiac mortalities, and MACE rates in DM patients with moderate and high UA levels were significantly higher than those in the NDM group (P=0.001). Long-term survival rates decreased significantly with increased UA levels in the ACS groups (P=0.001). UA (odds ratio (OR)=2.106, 95% confidence interval (CI)=1.244‒3.568, P=0.006) was found to be an independent risk factor for all-cause mortality and MACE in elderly ACS patients with DM. The cutoff value of UA was 353.6 μmol/L (sensitivity, 67.4%; specificity, 65.7%). CONCLUSIONS: Serum UA level is a strong independent predictor of long-term all-cause death and MACE in elderly ACS patients with DM.
Authors: Giacomo Levantesi; Rosa Maria Marfisi; Maria Grazia Franzosi; Aldo Pietro Maggioni; Gian Luigi Nicolosi; Carlo Schweiger; Maria Giuseppina Silletta; Luigi Tavazzi; Gianni Tognoni; Roberto Marchioli Journal: Int J Cardiol Date: 2012-01-20 Impact factor: 4.164
Authors: Preethi Mani; Rishi Puri; Gregory G Schwartz; Steven E Nissen; Mingyuan Shao; John J P Kastelein; Venu Menon; A Michael Lincoff; Stephen J Nicholls Journal: JAMA Cardiol Date: 2019-04-01 Impact factor: 14.676
Authors: Clive R Pullinger; Patricia M O'Connor; Josefina M Naya-Vigne; Steven T Kunitake; Irina Movsesyan; Philip H Frost; Mary J Malloy; John P Kane Journal: J Am Heart Assoc Date: 2021-03-17 Impact factor: 5.501
Authors: Eliezer J Tassone; Antonio Cimellaro; Maria Perticone; Marta L Hribal; Angela Sciacqua; Francesco Andreozzi; Giorgio Sesti; Francesco Perticone Journal: Front Endocrinol (Lausanne) Date: 2018-03-26 Impact factor: 5.555